Anterix stockholders approve 1.0 million share increase to 2023 Stock Plan
At its August 4, 2026 annual meeting, Anterix stockholders approved Amendment No. 2 to the 2023 Stock Plan, which adds 1.0 million shares of common stock available for issuance, and elected seven directors. Stockholders also approved the advisory say-on-pay vote and ratified Deloitte & Touche LLP as auditor, so the plan change adds share capacity for future equity awards.
Key points
- Plan amendment approved with 13,558,280 votes for and 1,099,125 against; it adds 1.0 million shares to the 2023 Stock Plan
- Seven directors elected, including Jeffrey A. Altman and Mahvash Yazdi, to serve until the 2027 Annual Meeting
- Advisory vote on executive compensation approved with 14,641,617 votes for and 15,894 against; stockholders chose a one-year frequency for future votes
- Deloitte & Touche LLP ratified for the fiscal year ending March 31, 2027; quorum was about 90.06% of eligible shares
The filing
Written by AI on Nov 9, 2026, 8:36 AM ET, from this filing only. Written later: this filing was briefed after the fact, when past filings were added to the site, so the brief may be read with hindsight; the filing itself is the record of what was known on August 06, 2026.
Briefs are written by AI from the filing text and can contain mistakes — open the filing before acting on anything. Impact (1-5) and tone are the AI's reading of the filing for shareholders, not a price forecast. Not investment advice.